天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >CA-4948
CA-4948
  • CA-4948

CA-4948 NEW

Price $30 $70 $89
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: CA-4948 CAS No.: 1801344-14-8
Purity: 99.62% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameCA-4948
DescriptionCA-4948 (Emavusertib) is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.
In vitroCA-4948, demonstrated good cellular activity in ABC DLBCL and AML cell lines.?Inhibition of TLR signaling leading to decreased IL-6 levels was also observed in whole blood assays.?CA-4948 demonstrated moderate to high selectivity in a panel of 329 kinases as well as exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation.?CA-4948 was well tolerated in toxicity studies in both mouse and dog at efficacious exposure.?The overall profile of CA-4948 prompted us to select it as a clinical candidate for evaluation in patients with relapsed or refractory hematologic malignancies including non-Hodgkin lymphoma and acute myeloid leukemia[2].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationH2O : < 0.1 mg/mL (insoluble)
DMSO : 27.78 mg/mL (56.52 mM), Sonication is recommended.
Keywordsrheumatoid | inflammation | CD135 | inhibit | IL-1R associated kinase | CA4948 | lymphoma | Interleukin-1 receptor associated kinase | Fms like tyrosine kinase 3 | FLT3 | arthritis | Inhibitor | Cluster of differentiation antigen 135 | Myd88 | CA 4948 | IL-1R | IRAK | Toll | CA-4948
Inhibitors RelatedUNC2025 | Gilteritinib | Fedratinib | Nintedanib | Sunitinib | Sunitinib Malate | Sorafenib | Tandutinib | ANTHRAQUINONE-2-CARBOXYLIC ACID | Pexidartinib | Thalidomide 4-fluoride | Sorafenib tosylate
Related Compound LibrariesBioactive Compound Library | Tyrosine Kinase Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/100MG
VIP1Y
Hubei Chuchang Biotech Co., Ltd.
2024-04-17
$0.00/25Kg/Bag
VIP4Y
Sinoway Industrial co., ltd.
2022-07-19
$2420.00/25mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-07
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY